Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?

Application of guidelines for aminoglycosides use in French hospitals in 2013–2014

(2017) J. Robert et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

MIC-based dose adjustment: facts and fables

(2017) Johan W Mouton et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America

(2016) Tamar F. Barlam et al.   CLINICAL INFECTIOUS DISEASES

The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France

(2016) A. Charmillon et al.   CLINICAL MICROBIOLOGY AND INFECTION

Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals

(2016) Jan-Frederik Schlender et al.   CLINICAL PHARMACOKINETICS

Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review

(2016) Abi Jenkins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis

(2016) Kevin J. Downes et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmakokinetik und Pharmakodynamik von Antibiotika in der Intensivmedizin

(2016) F. Sörgel et al.   Medizinische Klinik-Intensivmedizin und Notfallmedizin

Assessment of the National French recommendations regarding the dosing regimen of 8mg/kg of gentamicin in patients hospitalised in intensive care units

(2016) Nicolas Allou et al.   Anaesthesia Critical Care & Pain Medicine

Investigation of the Clinical Efficacy and Dosage of Intravenous Ciprofloxacin in Patients with Respiratory Infection

(2016) Mitsutoshi Satoh   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Once-daily aminoglycoside dosing: An update on current literature

(2015) M. S. Stankowicz et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

(2015) Larry M. Baddour et al.   CIRCULATION

Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis

(2015) T. Steinmetz et al.   CLINICAL MICROBIOLOGY AND INFECTION

2015 ESC Guidelines for the management of infective endocarditis

(2015) Gilbert Habib et al.   EUROPEAN HEART JOURNAL

Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study

(2015) Angela Huttner et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Relative contribution of biological variation and technical variables to zone diameter variations of disc diffusion susceptibility testing

(2015) Michael Hombach et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Altered Pharmacokinetics of Piperacillin in Febrile Neutropenic Patients with Hematological Malignancy

(2014) Fekade Bruck Sime et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Individualization of Piperacillin Dosing for Critically Ill Patients: Dosing Software To Optimize Antimicrobial Therapy

(2014) T. W. Felton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Exposure to Ceftobiprole Is Associated with Microbiological Eradication and Clinical Cure in Patients with Nosocomial Pneumonia

(2014) A. E. Muller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current  -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

(2014) J. A. Roberts et al.   CLINICAL INFECTIOUS DISEASES

Teicoplanin therapy for MRSA bacteraemia: a retrospective study emphasizing the importance of maintenance dosing in improving clinical outcomes

(2014) C.-H. Lee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

An international, multicentre survey of  -lactam antibiotic therapeutic drug monitoring practice in intensive care units

(2014) G. Wong et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

(2014) Jason A Roberts et al.   LANCET INFECTIOUS DISEASES

Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?

(2013) Gloria Wong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Pharmacodynamics of Antipseudomonal Cephalosporins in Patients with Ventilator-Associated Pneumonia

(2013) Shawn H. MacVane et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High-dose regimen to achieve novel target trough concentration in teicoplanin

(2013) Takashi Ueda et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Benchmarking Therapeutic Drug Monitoring Software: A Review of Available Computer Tools

(2012) Aline Fuchs et al.   CLINICAL PHARMACOKINETICS

Dosing of antibiotics in obesity

(2012) Brett Janson et al.   CURRENT OPINION IN INFECTIOUS DISEASES

What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance

(2012) Andrew A. Udy et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Optimal exposures of ceftazidime predict the probability of microbiological and clinical outcome in the treatment of nosocomial pneumonia

(2012) A. E. Muller et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring

(2012)   MEDECINE ET MALADIES INFECTIEUSES

Antibiotic Dosing in Multiple Organ Dysfunction Syndrome

(2011) Marta Ulldemolins et al.   CHEST

Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients

(2011) Andrew A. Udy et al.   CHEST

Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective

(2011) Johan W. Mouton et al.   DRUG RESISTANCE UPDATES

Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations

(2011) D. Khachman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Population Pharmacokinetic Comparison and Pharmacodynamic Breakpoints of Ceftazidime in Cystic Fibrosis Patients and Healthy Volunteers

(2010) J. B. Bulitta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy

(2010) Annie Wong-Beringer et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health‐System Pharmacists, and the Society of Infectious Diseases Pharmacists

(2009) Michael J. Rybak et al.   CLINICAL INFECTIOUS DISEASES

Pharmacokinetic issues for antibiotics in the critically ill patient

(2009) Jason A. Roberts et al.   CRITICAL CARE MEDICINE

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

(2008) Peggy S. McKinnon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Ciprofloxacin pharmacokinetics in critically ill patients: A prospective cohort study

(2008) Arthur R.H. van Zanten et al.   JOURNAL OF CRITICAL CARE

Suboptimal Aminoglycoside Dosing in Critically Ill Patients

(2008) Rhonda S Rea et al.   THERAPEUTIC DRUG MONITORING